# A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types

> **NCT07503808** · PHASE1 · RECRUITING · sponsor: **IDEAYA Biosciences** · enrollment: 150 (estimated)

## Conditions studied

- Esophageal Squamous Cell Carcinoma
- High Grade Serous Ovarian Cancer
- Head and Neck Squamous Cell Carcinoma
- Colorectal Cancer
- Castration-resistant Prostate Cancer
- Non Small Cell Lung Cancer
- Endometrium Cancer
- Triple Negative Breast Cancer

## Interventions

- **DRUG:** IDE034

## Key facts

- **NCT ID:** NCT07503808
- **Lead sponsor:** IDEAYA Biosciences
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-02-24
- **Primary completion:** 2027-07-30
- **Final completion:** 2027-07-30
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2026-03-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07503808

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07503808, "A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types". Retrieved via AI Analytics 2026-08-01 from https://api.ai-analytics.org/clinical/NCT07503808. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*